Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
22.28
+1.80 (8.79%)
At close: Aug 17, 2026, 4:00 PM EDT
22.39
+0.11 (0.49%)
After-hours: Aug 17, 2026, 7:07 PM EDT
Sutro Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 54.34 | 58.13 | 190.3 | 69.27 | 47.25 | 30.41 |
Short-Term Investments | 110.01 | 83.3 | 126.59 | 306.35 | 287.11 | 167.52 |
Cash & Short-Term Investments | 164.35 | 141.43 | 316.9 | 375.62 | 334.36 | 197.94 |
Cash Growth | -19.88% | -55.37% | -15.63% | 12.34% | 68.92% | -46.23% |
Receivables | 5.8 | 3.98 | 8.62 | 36.08 | 7.12 | 12.45 |
Prepaid Expenses | 5.5 | 5.52 | 17.8 | 9.85 | 11.67 | 8.12 |
Total Current Assets | 175.65 | 150.93 | 343.31 | 421.54 | 353.15 | 218.52 |
Property, Plant & Equipment | 16.82 | 21.55 | 35.87 | 44.76 | 51.06 | 51.59 |
Long-Term Investments | - | - | - | - | - | 68.78 |
Other Long-Term Assets | 1.99 | 1.35 | 8.03 | 4.44 | 2.73 | 2.53 |
Total Assets | 194.46 | 173.83 | 387.21 | 470.74 | 406.94 | 341.41 |
Accounts Payable | 3.36 | 7.57 | 10.48 | 9.44 | 4.8 | 6.01 |
Accrued Expenses | 22.19 | 33.71 | 40.13 | 34.1 | 24.83 | 17.07 |
Current Portion of Long-Term Debt | - | - | - | 4.06 | 12.5 | 9.38 |
Current Portion of Leases | 6.66 | 7.78 | 7.48 | 6.42 | 4.59 | 1.04 |
Current Income Taxes Payable | - | - | 0.02 | 15.17 | - | - |
Current Unearned Revenue | 6.46 | 10.56 | 69.78 | 20.67 | 16.76 | 5.5 |
Other Current Liabilities | 14.23 | 15.51 | 4.01 | 3.9 | 3.08 | 2.75 |
Total Current Liabilities | 52.9 | 75.13 | 131.89 | 93.75 | 66.55 | 41.74 |
Long-Term Debt | - | - | - | - | 3.77 | 15.74 |
Long-Term Leases | 4.12 | 7.89 | 15.67 | 23.15 | 29.57 | 31.22 |
Long-Term Unearned Revenue | 239.06 | 221.56 | 193.35 | 202.49 | 89.89 | - |
Other Long-Term Liabilities | 1.69 | 1.69 | 1.69 | 1.69 | 0.12 | 0.15 |
Total Liabilities | 297.78 | 306.28 | 342.61 | 321.09 | 189.9 | 88.84 |
Common Stock | 0.02 | 0.01 | 0.01 | 0.06 | 0.06 | 0.05 |
Additional Paid-In Capital | 951.7 | 845.48 | 831.42 | 708.98 | 670.22 | 586.24 |
Retained Earnings | -1,055 | -977.96 | -786.87 | -559.41 | -452.62 | -333.41 |
Comprehensive Income & Other | -0.06 | 0.02 | 0.04 | 0.02 | -0.62 | -0.31 |
Total Common Equity | -103.32 | -132.45 | 44.6 | 149.65 | 217.05 | 252.56 |
Shareholders' Equity | -103.32 | -132.45 | 44.6 | 149.65 | 217.05 | 252.56 |
Total Liabilities & Equity | 194.46 | 173.83 | 387.21 | 470.74 | 406.94 | 341.41 |
Total Debt | 10.78 | 15.67 | 23.15 | 33.64 | 50.43 | 57.37 |
Net Cash (Debt) | 153.56 | 125.75 | 293.74 | 341.98 | 283.93 | 209.34 |
Net Cash Growth | -17.23% | -57.19% | -14.11% | 20.45% | 35.63% | -39.07% |
Net Cash Per Share | 13.15 | 14.80 | 37.97 | 56.84 | 55.96 | 45.39 |
Filing Date Shares Outstanding | 16.58 | 16.57 | 8.38 | 6.24 | 6.02 | 4.64 |
Total Common Shares Outstanding | 16.58 | 8.58 | 8.25 | 6.1 | 5.75 | 4.63 |
Working Capital | 122.75 | 75.79 | 211.42 | 327.8 | 286.61 | 176.78 |
Book Value Per Share | -6.23 | -15.43 | 5.40 | 24.53 | 37.75 | 54.52 |
Tangible Book Value | -103.32 | -132.45 | 44.6 | 149.65 | 217.05 | 252.56 |
Tangible Book Value Per Share | -6.23 | -15.43 | 5.40 | 24.53 | 37.75 | 54.52 |
Machinery | - | 25.51 | 42.12 | 40 | 37.63 | 31.82 |
Construction In Progress | - | 0.15 | 0.5 | 0.5 | 1.69 | 0.51 |
Leasehold Improvements | - | 12.34 | 24.21 | 23.61 | 23.22 | 23.65 |